152 related articles for article (PubMed ID: 35022440)
21. Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population.
Ravina M; Hess S; Chauhan MS; Jacob MJ; Alavi A
Clin Nucl Med; 2014 Sep; 39(9):767-71. PubMed ID: 24999677
[TBL] [Abstract][Full Text] [Related]
22. Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.
Sun L; Guan YS; Pan WM; Chen GB; Luo ZM; Wei JH; Wu H
World J Gastroenterol; 2008 Feb; 14(8):1212-7. PubMed ID: 18300346
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative.
Shiff B; Breau RH; Mallick R; Pouliot F; So A; Tanguay S; Kapoor A; Lattouf JB; Lavallée L; Fairey A; Finelli A; Bhindi B; Kawakami J; Rendon R; Bansal RK
Urol Oncol; 2021 Dec; 39(12):836.e19-836.e27. PubMed ID: 34556430
[TBL] [Abstract][Full Text] [Related]
24. One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.
Ito H; Kondo K; Kawahara T; Kaneta T; Tateishi U; Ueno D; Namura K; Kobayashi K; Miyoshi Y; Yumura Y; Makiyama K; Hayashi N; Hasumi H; Osaka K; Yokomizo Y; Teranishi JI; Hattori Y; Inoue T; Uemura H; Yao M; Nakaigawa N
Cancer Chemother Pharmacol; 2017 May; 79(5):855-861. PubMed ID: 28331985
[TBL] [Abstract][Full Text] [Related]
25. Preoperative imaging for colorectal liver metastases: a nationwide population-based study.
Elfrink AKE; Pool M; van der Werf LR; Marra E; Burgmans MC; Meijerink MR; den Dulk M; van den Boezem PB; Te Riele WW; Patijn GA; Wouters MWJM; Leclercq WKG; Liem MSL; Gobardhan PD; Buis CI; Kuhlmann KFD; Verhoef C; Besselink MG; Grünhagen DJ; Klaase JM; Kok NFM;
BJS Open; 2020 Aug; 4(4):605-621. PubMed ID: 32374497
[TBL] [Abstract][Full Text] [Related]
26. Comparison of diagnostic accuracy between [
Kanno M; Tsujikawa T; Narita N; Ito Y; Makino A; Imamura Y; Kimura H; Okazawa H; Fujieda S
Ann Nucl Med; 2020 Dec; 34(12):952-959. PubMed ID: 33040312
[TBL] [Abstract][Full Text] [Related]
27. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
28. FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma.
Nakaigawa N; Kondo K; Kaneta T; Tateishi U; Minamimoto R; Namura K; Ueno D; Kobayashi K; Kishida T; Ikeda I; Hasumi H; Makiyama K; Hayashi N; Osaka K; Muraoka K; Izumi K; Kawahara T; Teranishi JI; Miyoshi Y; Yumura Y; Uemura H; Inoue T; Yao M
Cancer Chemother Pharmacol; 2018 Apr; 81(4):739-744. PubMed ID: 29464355
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of 18-fluorodeoxyglucose positron emission tomography in the evaluation of tumor cardiac thrombus from renal cell carcinoma.
García JR; Simo M; Huguet M; Ysamat M; Lomeña F
Clin Transl Oncol; 2006 Feb; 8(2):124-8. PubMed ID: 16632427
[TBL] [Abstract][Full Text] [Related]
30. Utility of PET/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot's neuroarthropathy.
Rastogi A; Bhattacharya A; Prakash M; Sharma S; Mittal BR; Khandelwal N; Bhansali A
Nucl Med Commun; 2016 Dec; 37(12):1253-1259. PubMed ID: 27749777
[TBL] [Abstract][Full Text] [Related]
31. Restaging clear cell renal carcinoma with 18F-FDG PET/CT.
Fuccio C; Ceci F; Castellucci P; Spinapolice EG; Palumbo R; D'Ambrosio D; Bernardo A; Brunocilla E; Schiavina R; Maffione AM; Chondrogiannis S; Grassetto G; Colletti PM; Rubello D; Fanti S; Trifirò G
Clin Nucl Med; 2014 Jun; 39(6):e320-4. PubMed ID: 24566409
[TBL] [Abstract][Full Text] [Related]
32. Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging Predicts Vein Wall Scarring and Statin Benefit in Murine Venous Thrombosis.
Kessinger CW; Qi G; Hassan MZO; Henke PK; Tawakol A; Jaffer FA
Circ Cardiovasc Imaging; 2021 Mar; 14(3):e011898. PubMed ID: 33724049
[TBL] [Abstract][Full Text] [Related]
33. 18F-FDG-PET/CT in potentially advanced renal cell carcinoma: a role in treatment decisions and prognosis estimation.
Ferda J; Ferdova E; Hora M; Hes O; Finek J; Topolcan O; Kreuzberg B
Anticancer Res; 2013 Jun; 33(6):2665-72. PubMed ID: 23749925
[TBL] [Abstract][Full Text] [Related]
34. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of
Nakamoto Y; Ishimori T; Shimizu Y; Sano K; Togashi K
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1524-1530. PubMed ID: 30847538
[TBL] [Abstract][Full Text] [Related]
36. Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement.
Nicolau C; Sala E; Kumar A; Goldman DA; Schoder H; Hricak H; Vargas HA
AJR Am J Roentgenol; 2017 Apr; 208(4):849-853. PubMed ID: 28095016
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ
Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043
[TBL] [Abstract][Full Text] [Related]
38. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
39. Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis.
Park S; Lee HY; Lee S
J Cancer Res Clin Oncol; 2022 Jan; 148(1):215-224. PubMed ID: 34106327
[TBL] [Abstract][Full Text] [Related]
40. 99mTc-Methionine Hybrid SPECT/CT for Detection of Recurrent Glioma: Comparison With 18F-FDG PET/CT and Contrast-Enhanced MRI.
Arora G; Sharma P; Sharma A; Mishra AK; Hazari PP; Biswas A; Garg A; Aheer D; Kumar R
Clin Nucl Med; 2018 May; 43(5):e132-e138. PubMed ID: 29517540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
